<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01624129</url>
  </required_header>
  <id_info>
    <org_study_id>2011_0023</org_study_id>
    <nct_id>NCT01624129</nct_id>
  </id_info>
  <brief_title>New Serological Markers for Eosinophilic Esophagitis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universit채t M체nchen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universit채t M체nchen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate if serological parameters such as &quot;extracellular
      Serum-Tryptase (ST)&quot; and &quot;eosinophilic cationic protein (ECP)&quot; are useful for the diagnosis
      and surveillance of the eosinophilic esophagitis (EE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The eosinophilic esophagitis (EE) is chronic inflammatory and immunological disease. The
      diagnosis of EE is based upon large numbers of eosinophils in the esophagus on
      histopathologic examination (&gt; 20 eosinophils per high powered field in at least one
      specimen) despite acid suppression with a Proton-Pump-Inhibitor (PPI) for at least two weeks.

      There are no diagnostic serological markers for EE so far, so that the purpose of the study
      is to investigate serological markers which are established in other allergic diseases.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Eosinophilic Esophagitis</condition>
  <arm_group>
    <arm_group_label>eosinophilic esophagitis</arm_group_label>
    <description>patients with histopathological defined eosinophilic esophagitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluticasone</intervention_name>
    <description>Guideline-based treatment with fluticasone 0,5 ml (1-0-1), step-up or step-down after 3 months based on the histopathological findings</description>
    <arm_group_label>eosinophilic esophagitis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histopathological defined eosinophilic esophagitis

          -  Age: 18-80

        Exclusion Criteria:

          -  missing consent form

          -  contraindications for performing esophagogastroscopy/taking biopsies of the esophagus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Monther Bajbouj, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technical University of Munich, 2nd Medical Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monther Bajbouj, MD</last_name>
    <phone>+49-89-41402450</phone>
    <email>monther.bajbouj@lrz.tum.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christoph Schlag, MD</last_name>
    <phone>+49-89-41402450</phone>
    <email>Christoph.Schlag@lrz.tum.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>II. Medical Department, Technical University Munich</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monther Bajbouj, MD</last_name>
      <phone>0049-89-41400</phone>
      <email>monther.bajbouj@lrz.tum.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 8, 2011</study_first_submitted>
  <study_first_submitted_qc>June 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2012</study_first_posted>
  <last_update_submitted>June 16, 2012</last_update_submitted>
  <last_update_submitted_qc>June 16, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophagitis</mesh_term>
    <mesh_term>Eosinophilic Esophagitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluticasone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

